In the case of the HDAC inhibitor LAQ824, however, decreases in GPC and GPE and cellular energetics were exclusively recorded in tumours, in contrast to the increase in PC, which was observed in cells and tumours alike. This evidence concerns the gene HDAC9 and neoplasm.